Completely agree with you @kdwc, If I remember correctly the IPO was issued at $0.73 in 2020 and 4DX has achieved a significant milestone in last 3 years and surprisingly is still trading16% below the IPO price. As I said in my previous comment, the current share price is significantly undervalued and hitting a target of $1.2 - $1.5 shouldn't be that far. Liquidity is very low at this level and many holders, I believe do not want to sell their shares at this price when a bright future is not distant.
Ann: 4DMedical Investor Presentation - September 2022, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
63.0¢ |
Change
0.185(41.6%) |
Mkt cap ! $258.6M | |||
| Open | High | Low | Value | Volume |
| 58.0¢ | 66.5¢ | 53.0¢ | $4.659M | 7.693M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20000 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 63.0¢ | 635 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |